慢性病幼儿百白破、麻腮风及脊灰疫苗的接种完整性与及时性:系统综述
该系统综述检索至2018年5月8日的MEDLINE、Embase、DARE和CINAHL,纳入21项研究,评估早产、低出生体重或生命早期诊断慢性病婴儿中百白破、麻腮风及含脊灰疫苗的接种覆盖与及时性。结果显示这些人群的覆盖率估计差异很大,各疫苗和人群组间范围为40%至100%。结论指出缺乏报告特殊人群常规免疫覆盖与及时性的研究,建议改进监测并规范报告实践。
要点
- 特殊人群(早产、低出生体重、慢性病)常规免疫覆盖与及时性研究不足。
- 纳入研究中疫苗覆盖率估计差异大,范围为40%至100%。
- 建议改进特殊人群婴儿免疫状态监测并标准化报告实践。
核心结论
- 特殊人群儿童常规免疫覆盖与及时性研究缺乏,覆盖率估计差异大(40%至100%)。
- 需要改进特殊人群婴儿免疫状态监测并标准化报告实践。
研究设计与样本
- 系统综述,检索MEDLINE、Embase、DARE和CINAHL至2018年5月8日,纳入21项研究。
主要发现
- 各疫苗和人群组间覆盖率估计范围为40%至100%,差异很大。
临床怎么用
- 临床应关注早产、低出生体重及慢性病婴儿的常规免疫接种状态。
局限性
- 缺乏报告特殊人群常规免疫覆盖与及时性的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically review literature on uptake and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and/or polio-containing vaccines ininfants who were born preterm, with a low birth weight, and/or with chronic health conditions that were diagnosed within the first 6 months of life. METHODS: Using a standardized search strategy developed by a medical librarian, records were extracted from MEDLINE, Embase, Database of Abstracts of Reviews of Effects, and CINAHL up to May 8, 2018. RESULTS: Out of the 1997 records that were screened, we identified 21 studies that met inclusion criteria. Eleven studies assessed vaccine coverage and/or timeliness in preterm infants, 6 in low birth weight infants, and 7 in children with chronic health conditions. Estimates of coverage in these populations were highly variable, ranging from 40% to 100% across the vaccines and population groups. CONCLUSIONS: There is a lack of studies reporting coverage and timeliness of routine immunizations in special populations of children. POLICY IMPLICATIONS: Our review suggests a need for improved surveillance of immunization status in special populations of infants, as wellas aneed for standardization of reporting practices.
引用
- Walker EJ, MacDonald NE, Islam N, et al. Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review. Vaccine. 2019. PMID: 30814030. doi:10.1016/j.vaccine.2019.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。